Compare CNTB & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTB | HYI |
|---|---|---|
| Founded | 2012 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 143.8M |
| IPO Year | 2020 | N/A |
| Metric | CNTB | HYI |
|---|---|---|
| Price | $3.13 | $10.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 131.3K | 47.2K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.59% |
| EPS Growth | ★ 75.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,033,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,706.72 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.51 | $10.68 |
| 52 Week High | $3.28 | $12.12 |
| Indicator | CNTB | HYI |
|---|---|---|
| Relative Strength Index (RSI) | 64.39 | 34.33 |
| Support Level | $2.09 | N/A |
| Resistance Level | $3.23 | $11.21 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 85.53 | 16.22 |
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.